Literature DB >> 15997246

Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study.

T Salopuro1, L Pulkkinen, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, J Tuomilehto, M Laakso, M Uusitupa.   

Abstract

OBJECTIVE: Genetic variation in leptin receptor (LEPR) gene has been reported to associate with insulin and glucose metabolism and adiposity in different study settings and various populations. We wanted to evaluate the association between LEPR polymorphisms, diabetes risk and body weight in Finnish subjects with impaired glucose tolerance (IGT).
METHODS: We investigated the associations of the three LEPR polymorphisms (Lys109Arg, Gln223Arg, 3'UTR Del/Ins) with the conversion to type 2 diabetes and the changes in body weight in 507 individuals with IGT participating in the Finnish Diabetes Prevention Study. Participants were randomized to either an intensive diet and exercise intervention group or a control group.
RESULTS: After 3 years, the odds ratio for the development of type 2 diabetes in individuals in the control group with the Lys109Lys genotype was 2.38-fold higher than in individuals with other genotype combinations (P=0.016). Irrespective of group individuals with the Gln223Gln genotype had higher conversion to type 2 diabetes (OR 2.01 (95% CI 1.03-3.93)) than the Arg223 allele carriers (P=0.042). The risk was more pronounced in the control group than in the intervention group. Individuals having the 3'UTR Del/Del genotype had a slightly higher body weight throughout the study than those with the insertion allele (P=0.020), although no difference in weight change was observed.
CONCLUSION: Two polymorphisms (Lys109Arg, Gln223Arg) in the extracellular domain of the leptin receptor predicted the conversion to type 2 diabetes in high-risk individuals with IGT. The Del/Ins polymorphism in the 3'UTR of LEPR was associated with body weight.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997246     DOI: 10.1038/sj.ijo.0803024

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  20 in total

Review 1.  Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes.

Authors:  Peter Weyrich; Norbert Stefan; Hans-Ulrich Häring; Markku Laakso; Andreas Fritsche
Journal:  J Mol Med (Berl)       Date:  2006-12-13       Impact factor: 4.599

2.  Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice.

Authors:  Sulin Wu; Rebecca Mar-Heyming; Eric Z Dugum; Nicholas A Kolaitis; Hongxiu Qi; Päivi Pajukanta; Lawrence W Castellani; Aldons J Lusis; Thomas A Drake
Journal:  Hum Mol Genet       Date:  2009-12-08       Impact factor: 6.150

3.  Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Juan Pedro Kusanovic; Edi Vaisbuch; Offer Erez; Nandor Gabor Than; Tinnakorn Chaiworapongsa; Chia-Ling Nhan-Chang; Percy Pacora; Francesca Gotsch; Lami Yeo; Sun Kwon Kim; Samuel S Edwin; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

4.  Maternal serum adiponectin multimers in gestational diabetes.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Offer Erez; Pooja Mittal; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Percy Pacora; Lami Yeo; Francesca Gotsch; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

5.  Genome-wide association study identifies polymorphisms in LEPR as determinants of plasma soluble leptin receptor levels.

Authors:  Qi Sun; Marilyn C Cornelis; Peter Kraft; Lu Qi; Rob M van Dam; Cynthia J Girman; Cathy C Laurie; Daniel B Mirel; Huizi Gong; Chau-Chyun Sheu; David C Christiani; David J Hunter; Christos S Mantzoros; Frank B Hu
Journal:  Hum Mol Genet       Date:  2010-02-17       Impact factor: 6.150

6.  Polymorphisms in the leptin receptor (LEPR)--putative association with obesity and T2DM.

Authors:  Kyong Soo Park; Hyoung Doo Shin; Byung Lae Park; Hyun Sub Cheong; Young Min Cho; Hong Kyu Lee; Jong-Young Lee; Jong-Keuk Lee; Bermseok Oh; Kuchan Kimm
Journal:  J Hum Genet       Date:  2005-12-07       Impact factor: 3.172

7.  Effect of genetic variation in the leptin gene promoter and the leptin receptor gene on obesity risk in a population-based case-control study in Spain.

Authors:  Olga Portolés; José Vicente Sorlí; Francesc Francés; Oscar Coltell; Jose I González; Carmen Sáiz; Dolores Corella
Journal:  Eur J Epidemiol       Date:  2006-09-20       Impact factor: 12.434

8.  Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome.

Authors:  Mark Waterlow; Paul Chrisp
Journal:  Core Evid       Date:  2008-02-29

9.  Variations in Adipokine Genes AdipoQ, Lep, and LepR are Associated with Risk for Obesity-Related Metabolic Disease: The Modulatory Role of Gene-Nutrient Interactions.

Authors:  Jennifer Emily Enns; Carla G Taylor; Peter Zahradka
Journal:  J Obes       Date:  2011-04-19

10.  Association of leptin receptor gene polymorphisms and essential hypertension in a Chinese population.

Authors:  P Gu; W Jiang; M Chen; B Lu; J Shao; H Du; S Jiang
Journal:  J Endocrinol Invest       Date:  2012-01-30       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.